• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Brand Quest
• The New Manager
• BL Club
• Smartbuy
• Books
• Gallery

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth
• Events 2007

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Chennai, Sept. 25

Sri Ramachandra University has signed an agreement with the multinational pharmaceutical company Pfizer for setting up its preferred research centre, according to a press release from the university. This centre will jointly offer training programmes in clinical research on protocol writing, advanced good clinical practices and all about clinical trials. This will enable the university to strengthen clinical trial division by developing standard operating procedures, training and accreditation. Pfizer would provide Rs 35 lakh as grant for carrying out these activities in addition to providing training materials and resource persons for the programmes.

More Stories on : Research & Development | Education | Tamil Nadu

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Copyright © 2009, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line